Variant report

Variant	esv3442194
Chromosome Location	chr19:18403852-18408550
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:42)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:42 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:18219734..18221957-chr19:18401756..18404165,2	K562	blood:
2	chr19:18402236..18405343-chr19:18407767..18411691,5	MCF-7	breast:
3	chr19:18402934..18404440-chr19:18413861..18416059,2	MCF-7	breast:
4	chr19:18404209..18404971-chr19:18433852..18434686,2	MCF-7	breast:
5	chr19:18404342..18405851-chr19:18528266..18530065,2	K562	blood:
6	chr19:18401578..18404276-chr19:18423557..18426532,3	MCF-7	breast:
7	chr19:18401391..18404924-chr19:18547602..18550007,3	K562	blood:
8	chr1:185285767..185286450-chr19:18403581..18404468,2	Hela-S3	cervix:
9	chr19:18399345..18407720-chr19:18430417..18436364,18	MCF-7	breast:
10	chr19:18403797..18404346-chr6:49430498..49431216,2	Hela-S3	cervix:
11	chr19:18402354..18403931-chr19:18474234..18475784,2	K562	blood:
12	chr19:18283000..18284666-chr19:18403013..18404527,2	K562	blood:
13	chr16:31191417..31192171-chr19:18403741..18404517,2	Hela-S3	cervix:
14	chr19:18404019..18405840-chr19:18495699..18498623,2	K562	blood:
15	chr19:18403506..18405273-chr19:18495493..18497035,2	MCF-7	breast:
16	chr19:18391866..18392862-chr19:18402555..18404386,6	Hela-S3	cervix:
17	chr19:18283000..18284595-chr19:18402682..18404527,2	K562	blood:
18	chr19:18399894..18406849-chr19:18524216..18528146,7	K562	blood:
19	chr19:18403869..18405771-chr19:18450788..18452499,2	MCF-7	breast:
20	chr19:18351413..18353235-chr19:18403672..18406374,2	K562	blood:
21	chr19:18404019..18405946-chr19:18496995..18498623,2	K562	blood:
22	chr19:18389740..18392498-chr19:18405521..18407514,3	MCF-7	breast:
23	chr19:18397375..18399268-chr19:18401136..18404109,3	MCF-7	breast:
24	chr19:18401356..18404646-chr19:18426877..18430398,3	MCF-7	breast:
25	chr19:18401371..18405274-chr19:18416257..18419267,5	MCF-7	breast:
26	chr19:18401957..18405099-chr19:18441028..18445565,5	MCF-7	breast:
27	chr19:18401679..18404402-chr19:18698590..18700226,2	K562	blood:
28	chr19:18401175..18404023-chr19:18537863..18539807,2	K562	blood:
29	chr19:18383365..18408325-chr19:18518460..18533256,66	K562	blood:
30	chr1:27324097..27324814-chr19:18403431..18403991,2	HCT-116	colon:
31	chr15:65587972..65588859-chr19:18403872..18404756,2	Hela-S3	cervix:
32	chr19:18392200..18393137-chr19:18403826..18404739,2	MCF-7	breast:
33	chr19:18402879..18404490-chr19:18483382..18485469,2	K562	blood:
34	chr19:18402536..18404490-chr19:18452623..18454131,2	MCF-7	breast:
35	chr19:18402236..18405343-chr19:18407767..18411691,5	MCF-7	breast:
36	chr19:18302170..18305660-chr19:18401195..18405858,4	K562	blood:
37	chr19:18401829..18404172-chr19:18534025..18536659,2	K562	blood:
38	chr19:18392200..18392869-chr19:18403826..18404373,3	MCF-7	breast:
39	chr19:18319878..18322618-chr19:18403582..18405708,2	K562	blood:
40	chr19:679966..680526-chr19:18403602..18404571,2	Hela-S3	cervix:
41	chr19:18402179..18405355-chr19:18483969..18486713,5	K562	blood:
42	chr19:18403785..18405926-chr21:38617800..38619973,2	K562	blood:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PGPEP1-3	chr19:18408032-18408552	NONHSAT062958
2	lnc-PGPEP1-4	chr19:18407534-18407915	NONHSAT062957

No data

Variant related genes	Relation type
ENSG00000130513	chromatin interactions
ENSG00000267959	chromatin interactions
ENSG00000099308	chromatin interactions
ENSG00000216490	chromatin interactions
ENSG00000031691	chromatin interactions
ENSG00000239821	chromatin interactions
ENSG00000221167	chromatin interactions
ENSG00000130522	chromatin interactions
ENSG00000089280	chromatin interactions
ENSG00000006015	chromatin interactions
ENSG00000146085	chromatin interactions
ENSG00000070404	chromatin interactions
ENSG00000116679	chromatin interactions
ENSG00000130520	chromatin interactions
ENSG00000130517	chromatin interactions
ENSG00000130511	chromatin interactions
ENSG00000264175	chromatin interactions
ENSG00000199568	chromatin interactions
ENSG00000105655	chromatin interactions
ENSG00000254858	chromatin interactions

Extended variants
information (count: 188 )
Associated
traits (count: 59 )

Variant overlapped rSNPs/rCNVs (count:188 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs552441300	chr19:18403853-18403854	Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	17 gene(s)	Overlapped CNVs	n/a
2	rs559364140	chr19:18403875-18403876	Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	19 gene(s)	Overlapped CNVs	n/a
3	rs543671393	chr19:18403876-18403877	Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	19 gene(s)	Overlapped CNVs	n/a
4	rs563437770	chr19:18403918-18403919	Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	19 gene(s)	Overlapped CNVs	n/a
5	rs114922303	chr19:18403943-18403944	Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	19 gene(s)	Overlapped CNVs	n/a
6	rs551352527	chr19:18403945-18403946	Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	19 gene(s)	Overlapped CNVs	n/a
7	rs111295411	chr19:18404055-18404056	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS	Chromatin interactive region	20 gene(s)	Overlapped CNVs	n/a
8	rs186734851	chr19:18404064-18404065	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS	Chromatin interactive region	20 gene(s)	Overlapped CNVs	n/a
9	rs527758698	chr19:18404067-18404068	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS	Chromatin interactive region	20 gene(s)	Overlapped CNVs	n/a
10	rs547610409	chr19:18404114-18404115	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS	Chromatin interactive region	20 gene(s)	Overlapped CNVs	n/a
11	rs10419232	chr19:18404148-18404149	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS	Chromatin interactive region	20 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs536468724	chr19:18404186-18404187	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS	Chromatin interactive region	19 gene(s)	Overlapped CNVs	n/a
13	rs550404802	chr19:18404190-18404191	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS	Chromatin interactive region	19 gene(s)	Overlapped CNVs	n/a
14	rs368286956	chr19:18404223-18404224	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	19 gene(s)	Overlapped CNVs	n/a
15	rs539383626	chr19:18404341-18404342	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	19 gene(s)	Overlapped CNVs	n/a
16	rs558585850	chr19:18404363-18404364	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	17 gene(s)	Overlapped CNVs	n/a
17	rs140561951	chr19:18404393-18404394	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	17 gene(s)	Overlapped CNVs	n/a
18	rs74442027	chr19:18404437-18404438	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	16 gene(s)	Overlapped CNVs	n/a
19	rs554387876	chr19:18404479-18404480	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	15 gene(s)	Overlapped CNVs	n/a
20	rs574526425	chr19:18404514-18404515	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	15 gene(s)	Overlapped CNVs	n/a
21	rs543260065	chr19:18404533-18404534	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	13 gene(s)	Overlapped CNVs	n/a
22	rs563802519	chr19:18404538-18404539	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	13 gene(s)	Overlapped CNVs	n/a
23	rs563182657	chr19:18404551-18404552	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	13 gene(s)	Overlapped CNVs	n/a
24	rs576722412	chr19:18404556-18404557	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	13 gene(s)	Overlapped CNVs	n/a
25	rs150443407	chr19:18404573-18404574	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
26	rs537137688	chr19:18404650-18404651	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
27	rs372036485	chr19:18404653-18404654	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
28	rs527695588	chr19:18404665-18404666	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
29	rs547841726	chr19:18404680-18404681	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
30	rs60086589	chr19:18404718-18404719	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	12 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
31	rs193129919	chr19:18404721-18404722	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
32	rs564698297	chr19:18404740-18404741	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
33	rs374179206	chr19:18404741-18404742	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
34	rs201878760	chr19:18404743-18404744	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
35	rs550100357	chr19:18404762-18404763	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
36	rs369985013	chr19:18404781-18404782	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
37	rs528235188	chr19:18404793-18404794	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
38	rs570312684	chr19:18404799-18404800	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
39	rs539321162	chr19:18404886-18404887	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
40	rs12608474	chr19:18404902-18404903	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
41	rs55824062	chr19:18404903-18404904	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
42	rs397702680	chr19:18404906-18404907	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
43	rs552917654	chr19:18404923-18404924	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
44	rs4808779	chr19:18404936-18404937	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	8 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
45	rs149637334	chr19:18404940-18404941	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
46	rs554607793	chr19:18404941-18404942	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
47	rs568052537	chr19:18404972-18404973	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
48	rs535409639	chr19:18404997-18404998	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
49	rs185778752	chr19:18405085-18405086	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
50	rs556715193	chr19:18405101-18405102	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:59)

Disease	PMID	Source
Medulloblastoma	16783165	CNVD
Follicular lymphoma	20505157	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Non-syndromic sensorineural hearing loss	20179077	CNVD
Melanoma	18172304	CNVD
Glioblastoma multiforme	21080181	CNVD
Metanephric adenoma	20802469	CNVD
Prostate cancer	16573809	CNVD
Breast cancer	16608533	CNVD
Lung cancer	17297452	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Chordoma	18071362	CNVD
Ewing''s sarcoma	21437220	CNVD
Medulloblastoma	21979893	CNVD
Oligodendroglial tumors	17285580	CNVD
Oral cancer	21386901	CNVD
ovarian endometriomas	16273235	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Cervical cancer	21063398	CNVD
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Ovarian cancer	21720365	CNVD
Urothelial carcinoma	21177765	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Basal cell lymphoma	21115979	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Medullary thyroid carcinoma	18765511	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Breast cancer	21364760	CNVD
Mycobacterial infection	18421352	CNVD
Glioblastoma multiforme	22286061	CNVD
Acute monocytic leukemia	16498392	CNVD
Lung cancer	18438408	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Liver carcinoma	19366792	CNVD
Colorectal cancer	19455253	CNVD
Lujan-Fryns syndrom	21521776	CNVD
Breast cancer	20409316	CNVD
Cancer	17160897	CNVD
Cancer	17440070	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Breast cancer	21509527	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:388 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:18400600-18404400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
2	chr19:18400800-18404400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
3	chr19:18402000-18404000	Active TSS	iPS-18 Cell Line	embryonic stem cell
4	chr19:18402000-18404000	Active TSS	Rectal Smooth Muscle	rectum
5	chr19:18402000-18404000	Flanking Active TSS	Dnd41	blood
6	chr19:18402000-18404200	Active TSS	ES-I3 Cell Line	embryonic stem cell
7	chr19:18402000-18404200	Active TSS	ES-WA7 Cell Line	embryonic stem cell
8	chr19:18402000-18404200	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
9	chr19:18402000-18404200	Flanking Active TSS	Primary Natural Killer cells fromperipheralblood	blood
10	chr19:18402000-18404200	Flanking Active TSS	Fetal Intestine Small	intestine
11	chr19:18402000-18404400	Active TSS	H9 Cell Line	embryonic stem cell
12	chr19:18402000-18404400	Flanking Active TSS	Primary B cells from peripheral blood	blood
13	chr19:18402000-18404400	Flanking Active TSS	Primary T cells fromperipheralblood	blood
14	chr19:18402000-18404400	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
15	chr19:18402000-18404400	Flanking Active TSS	Muscle Satellite Cultured Cells	--
16	chr19:18402000-18404400	Flanking Active TSS	Fetal Adrenal Gland	Adrenal Gland
17	chr19:18402000-18404400	Flanking Active TSS	Fetal Muscle Trunk	muscle
18	chr19:18402000-18404400	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
19	chr19:18402000-18404600	Active TSS	HUES64 Cell Line	embryonic stem cell
20	chr19:18402000-18404600	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
21	chr19:18402000-18404600	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
22	chr19:18402000-18404800	Flanking Active TSS	Colonic Mucosa	Colon
23	chr19:18402000-18405800	Flanking Active TSS	Primary T helper 17 cells PMA-I stimulated	--
24	chr19:18402000-18405800	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
25	chr19:18402200-18404000	Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
26	chr19:18402200-18404000	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
27	chr19:18402200-18404000	Active TSS	HUES48 Cell Line	embryonic stem cell
28	chr19:18402200-18404000	Active TSS	HUES6 Cell Line	embryonic stem cell
29	chr19:18402200-18404000	Active TSS	iPS-15b Cell Line	embryonic stem cell
30	chr19:18402200-18404000	Active TSS	iPS-20b Cell Line	embryonic stem cell
31	chr19:18402200-18404000	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
32	chr19:18402200-18404000	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
33	chr19:18402200-18404000	Active TSS	Colon Smooth Muscle	Colon
34	chr19:18402200-18404200	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
35	chr19:18402200-18404200	Active TSS	Aorta	Aorta
36	chr19:18402200-18404200	Active TSS	Pancreatic Islets	Pancreatic Islet
37	chr19:18402200-18404200	Flanking Active TSS	Fetal Muscle Leg	muscle
38	chr19:18402200-18404200	Active TSS	Ovary	ovary
39	chr19:18402200-18404200	Active TSS	Right Atrium	heart
40	chr19:18402200-18404200	Active TSS	Right Ventricle	heart
41	chr19:18402200-18404400	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
42	chr19:18402200-18404400	Flanking Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
43	chr19:18402200-18404400	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
44	chr19:18402400-18404000	Active TSS	H1 Cell Line	embryonic stem cell
45	chr19:18402400-18404000	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
46	chr19:18402400-18404400	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
47	chr19:18402400-18404400	Active TSS	Fetal Kidney	kidney
48	chr19:18402400-18404400	Flanking Active TSS	Osteobl	bone
49	chr19:18402600-18404000	Active TSS	Lung	lung
50	chr19:18402600-18404000	Active TSS	Hela-S3	cervix

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links